SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 72.41 |
Enterprise Value ($M) | 63.41 |
Book Value ($M) | 39.20 |
Book Value / Share | 4.50 |
Price / Book | 1.85 |
NCAV ($M) | 39.20 |
NCAV / Share | 4.50 |
Price / NCAV | 1.85 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.42 |
Return on Assets (ROA) | -2.04 |
Return on Equity (ROE) | -3.05 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 11.11 |
Current Ratio | 11.11 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 43.08 |
Assets | 43.08 |
Liabilities | 3.88 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 9.74 |
Operating Income | -18.23 |
Net Income | -16.29 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -16.53 |
Cash from Investing | -28.66 |
Cash from Financing | 46.40 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Ra Capital Management, L.p. | 9.90 | 10.99 | |
13G/A | AWM Investment Company, Inc. | 4.70 | -52.57 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
87,115 | 323,078 | 26.96 | |
208,152 | 575,103 | 36.19 | |
123,700 | 434,761 | 28.45 | |
395,014 | 1,215,365 | 32.50 | |
(click for more detail) |
Similar Companies | |
---|---|
CRBP – Corbus Pharmaceuticals Holdings, Inc. | CRDF – Cardiff Oncology, Inc. |
CRIS – Curis, Inc. | CSBR – Champions Oncology, Inc. |
CSCI – COSCIENS Biopharma Inc. |
Financial data and stock pages provided by
Fintel.io